ADC Therapeutics (ADCT) Exchange Rate Effect (2020 - 2026)
ADC Therapeutics (ADCT) posted Exchange Rate Effect of -$5000.0 for Q1 2026, up 80.0% sequentially from -$25000.0 in Q4 2025, and down 103.11% YoY from $161000.0 in Q1 2025.
ADC Therapeutics (ADCT) Exchange Rate Effect (2020 - 2026) Analysis & Trends
ADC Therapeutics has reported Exchange Rate Effect for 7 years, with the latest figure at -$5000.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 103.11% year-over-year to -$5000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $139000.0 (up 14.88% YoY) and the FY2025 annual result came in at $305000.0, up 467.47% from the prior year.
- Exchange Rate Effect rose to -$5000.0 in Q1 2026 per ADCT's latest filing, from -$25000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $291000.0 in Q3 2024 and troughed at -$343000.0 in Q4 2024.
- A 5-year average of $11352.9 and a median of $6000.0 in 2025 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect sank 1066.67% in 2022, then surged 1258.33% in 2025.
- Over 5 years, Exchange Rate Effect stood at $243000.0 in 2022, then plunged by 37.45% to $152000.0 in 2023, then tumbled by 325.66% to -$343000.0 in 2024, then soared by 92.71% to -$25000.0 in 2025, then soared by 80.0% to -$5000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$5000.0, -$25000.0, and $6000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -2.45 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -287,000.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.63 Mn |
| 10 | ADC Therapeutics | 148.95 Mn | -70.15 Mn | 17.14 Mn | 5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5,000.00 |
| Jun 30, 2026 | 5,000.00 |
| Mar 31, 2026 | -5,000.00 |
| Mar 31, 2026 | -5,000.00 |
| Dec 31, 2025 | -25,000.00 |
| Dec 31, 2025 | -25,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 163,000.00 |
| Jun 30, 2025 | 163,000.00 |
| Mar 31, 2025 | 161,000.00 |
| Mar 31, 2025 | 161,000.00 |
| Dec 31, 2024 | -343,000.00 |
| Dec 31, 2024 | -343,000.00 |
| Sep 30, 2024 | 291,000.00 |
| Sep 30, 2024 | 291,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | -43,000.00 |
| Mar 31, 2024 | -43,000.00 |